Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald ...
A troubled Indiana contract manufacturing plant recently acquired by Novo Nordisk is considered to not be in compliance with FDA standards ...
WASHINGTON (AP) — The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional protein-based option for the coronavirus — is sowing ...
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the ...
Zacks Investment Research on MSN
Novavax (NVAX) Stock Sinks As Market Gains: Here's Why
Novavax (NVAX) closed at $8.52 in the latest trading session, marking a -2.07% move from the prior day. This change lagged the S&P 500's 0.23% gain on the day. Elsewhere, the Dow saw an upswing of ...
GAITHERSBURG, Md., Oct. 7, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the marketing authorization for its COVID-19 vaccine, Nuvaxovid® to Sanofi, in the European ...
Agreements signed to transfer one U.S.-based facility and sell certain equipment netting $60 million in cash and resulting in ...
FILE - A vial of the Phase 3 Novavax coronavirus vaccine prepared for use in a trial at St. George's University hospital in London, Oct. 7, 2020. (AP Photo/Alastair Grant, File) WASHINGTON (AP) — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results